Finance

Lists
Why is QIA up 2,65%?
Dive Deeper
QIA:FRA
Qiagen NV
40,42 €
+2,65%
(+1,05) 1D
9 ოქტ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for QIA...
Open
39,54 €
High
40,56 €
Low
39,54 €
Mkt. cap
8,42 მლრდ.
Avg. vol.
615,00
Volume
141,00
Dividend
0,76%
Quarterly dividend
0,08 €
Ex-dividend date
7 ივლ. 2026
P/E ratio
23,28
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 მლნ.
No. of employees
6 ათ.
Open
39,54 €
High
40,56 €
Low
39,54 €
Mkt. cap
8,42 მლრდ.
Avg. vol.
615,00
Volume
141,00
Dividend
0,76%
Quarterly dividend
0,08 €
Ex-dividend date
7 ივლ. 2026
P/E ratio
23,28
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 მლნ.
No. of employees
6 ათ.
News stories
From web sources and news partners
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOტიერი ბერნარ
Employees5,5 ათ.
Founded29 ნოე. 1984
Headquartersვენლო, ლიმბურგის პროვინცია, ნიდერლანდები
SectorHealth care
Websiteqiagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
532,58 მლნ.
540,42 მლნ.
492,32 მლნ.
535,04 მლნ.
Cost of goods sold
187,78 მლნ.
173,92 მლნ.
168,83 მლნ.
181,97 მლნ.
Cost of revenue
187,78 მლნ.
173,92 მლნ.
168,83 მლნ.
181,97 მლნ.
Research and development expenses
48,75 მლნ.
47,24 მლნ.
48,26 მლნ.
50,43 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,11 მლნ.
153,88 მლნ.
142,39 მლნ.
146,77 მლნ.
Operating expense
207,51 მლნ.
218,30 მლნ.
206,24 მლნ.
212,22 მლნ.
Total operating expenses
395,29 მლნ.
392,22 მლნ.
375,06 მლნ.
394,19 მლნ.
Operating income
137,29 მლნ.
148,20 მლნ.
117,26 მლნ.
140,85 მლნ.
Other non operating income
-89,00 ათ.
-133,00 ათ.
193,00 ათ.
-35,00 ათ.
EBT including unusual items
134,73 მლნ.
109,17 მლნ.
85,83 მლნ.
132,10 მლნ.
EBT excluding unusual items
142,86 მლნ.
157,94 მლნ.
118,66 მლნ.
140,05 მლნ.
Income tax expense
4,68 მლნ.
1,34 მლნ.
17,79 მლნ.
28,70 მლნ.
Effective tax rate
3,48%
1,23%
20,72%
21,73%
Other operating expenses
-
-
-
-
Net income
130,04 მლნ.
107,83 მლნ.
68,04 მლნ.
103,40 მლნ.
Net profit margin
24,42%
19,95%
13,82%
19,33%
Earnings per share
-
0,62
0,54
0,62
Interest and investment income
15,07 მლნ.
20,00 მლნ.
10,56 მლნ.
9,36 მლნ.
Interest expense
-8,22 მლნ.
-10,14 მლნ.
-11,05 მლნ.
-10,02 მლნ.
Net interest expenses
6,85 მლნ.
9,86 მლნ.
-489,00 ათ.
-661,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
188,26 მლნ.
179,60 მლნ.
168,47 მლნ.
191,40 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები